FDA Approved: ALOCRIL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ALOCRIL (nedocromil sodium) from Allergan to update its labeling for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• ALOCRIL (NEDOCROMIL SODIUM)

Snippet

SUPPL AP for ALOCRIL (NEDOCROMIL SODIUM)